Trial results show setrusumab reduces the incidence of fracture and increases bone density and formation. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Add Yahoo as a preferred source to see more of our stories on Google. Osteogenesis imperfecta type 3 is an inherited (genetic) bone disorder that is present at birth, according to John Hopkins ...
SEATTLE -- Treating osteogenesis imperfecta with the parathyroid hormone teriparatide followed by zoledronic acid, a bisphosphonate, failed to reduce the risk of fractures compared with standard ...
NOVATO, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
The special issue 'Osteogenesis Imperfecta from Bench to Bedside and from Cradle to Grave', published in the journal Calcified Tissue International, is a compilation of 14 invited reviews and original ...
Free Malaysia Today on MSN
The unbreakable spirit of wheelchair fencer Daniel Lee
Living with a rare brittle bone disease, this sportsman refuses to be defined by his limits, pushing forward with tenacity ...
The MarketWatch News Department was not involved in the creation of this content. Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results